These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 35885067)

  • 1. Small Molecules and Immunotherapy Agents for Enhancing Radiotherapy in Glioblastoma.
    Matsui JK; Perlow HK; Ritter AR; Upadhyay R; Raval RR; Thomas EM; Beyer SJ; Pillainayagam C; Goranovich J; Ong S; Giglio P; Palmer JD
    Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35885067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioresistance in Glioblastoma and the Development of Radiosensitizers.
    Ali MY; Oliva CR; Noman ASM; Allen BG; Goswami PC; Zakharia Y; Monga V; Spitz DR; Buatti JM; Griguer CE
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32899427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy for glioblastoma: clinical issues and nanotechnology strategies.
    Li R; Wang H; Liang Q; Chen L; Ren J
    Biomater Sci; 2022 Feb; 10(4):892-908. PubMed ID: 34989724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinatorial approaches to effective therapy in glioblastoma (GBM): Current status and what the future holds.
    Asija S; Chatterjee A; Yadav S; Chekuri G; Karulkar A; Jaiswal AK; Goda JS; Purwar R
    Int Rev Immunol; 2022; 41(6):582-605. PubMed ID: 35938932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances in the Therapeutic Strategies of Glioblastoma Multiforme.
    Aldoghachi AF; Aldoghachi AF; Breyne K; Ling KH; Cheah PS
    Neuroscience; 2022 May; 491():240-270. PubMed ID: 35395355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review.
    Fabian D; Guillermo Prieto Eibl MDP; Alnahhas I; Sebastian N; Giglio P; Puduvalli V; Gonzalez J; Palmer JD
    Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30717372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosensitizers in the temozolomide era for newly diagnosed glioblastoma.
    Mathen P; Rowe L; Mackey M; Smart D; Tofilon P; Camphausen K
    Neurooncol Pract; 2020 Jun; 7(3):268-276. PubMed ID: 32537176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioblastoma Treatment Modalities besides Surgery.
    Zhang H; Wang R; Yu Y; Liu J; Luo T; Fan F
    J Cancer; 2019; 10(20):4793-4806. PubMed ID: 31598150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor treating fields: a novel and effective therapy for glioblastoma: mechanism, efficacy, safety and future perspectives.
    Zhu P; Zhu JJ
    Chin Clin Oncol; 2017 Aug; 6(4):41. PubMed ID: 28841803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies.
    Mittal S; Klinger NV; Michelhaugh SK; Barger GR; Pannullo SC; Juhász C
    J Neurosurg; 2018 Feb; 128(2):414-421. PubMed ID: 28298023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
    Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
    Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporating genomic signatures into surgical and medical decision-making for elderly glioblastoma patients.
    Ene CI; Cimino PJ; Fine HA; Holland EC
    Neurosurg Focus; 2020 Oct; 49(4):E11. PubMed ID: 33002863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.
    Ziu M; Kim BYS; Jiang W; Ryken T; Olson JJ
    J Neurooncol; 2020 Nov; 150(2):215-267. PubMed ID: 33215344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor treating fields with radiation for glioblastoma: a narrative review.
    Miller R; Niazi M; Russial O; Poiset S; Shi W
    Chin Clin Oncol; 2022 Oct; 11(5):40. PubMed ID: 36336899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme.
    Chang JE; Khuntia D; Robins HI; Mehta MP
    Clin Adv Hematol Oncol; 2007 Nov; 5(11):894-902, 907-15. PubMed ID: 18185489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Update on the Role of Immunotherapy and Vaccine Strategies for Primary Brain Tumors.
    Neagu MR; Reardon DA
    Curr Treat Options Oncol; 2015 Nov; 16(11):54. PubMed ID: 26454859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deregulated MicroRNA Signature Following Glioblastoma Irradiation.
    Toraih EA; El-Wazir A; Abdallah HY; Tantawy MA; Fawzy MS
    Cancer Control; 2019; 26(1):1073274819847226. PubMed ID: 31046428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Success and Failures of Combined Modalities in Glioblastoma Multiforme: Old Problems and New Directions.
    Corso CD; Bindra RS
    Semin Radiat Oncol; 2016 Oct; 26(4):281-98. PubMed ID: 27619250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual blockage of STAT3 and ERK1/2 eliminates radioresistant GBM cells.
    Xie B; Zhang L; Hu W; Fan M; Jiang N; Duan Y; Jing D; Xiao W; Fragoso RC; Lam KS; Sun LQ; Li JJ
    Redox Biol; 2019 Jun; 24():101189. PubMed ID: 30986607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of newly diagnosed glioblastoma multiforme: current state of the art and emerging therapeutic approaches.
    McMahon DJ; Gleeson JP; O'Reilly S; Bambury RM
    Med Oncol; 2022 Jun; 39(9):129. PubMed ID: 35716200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.